RPO LLC’s AC Immune ACIU Stock Holding History

RPO LLC’s Portfolio ACIU Stock Details ACIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-18,728	Closed	-$50.6K	–	41
2024 Q4	$50.6K	Buy	+18,728	New	+$58.5K	0.05%	58

Other funds holding ACIU

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RPO LLC's ACIU Position: Q1 2025 in Review

RPO LLC sold out of AC Immune (ACIU) in Q1 2025, closing a stake of 18,728 shares — an estimated $50.6K sold.

RPO LLC first reported a position in ACIU in Q4 2024 and held it in 1 quarter. The position peaked at $50.6K in Q4 2024. 41 funds tracked by Wall St. Rank hold ACIU as of Q1 2025.

RPO LLC reported no remaining AC Immune position as of Q1 2025 after selling out during the quarter.
RPO LLC sold 18,728 AC Immune shares in Q1 2025, an estimated $50.6K.
RPO LLC first reported a position in AC Immune in Q4 2024 and held it in 1 quarter.
RPO LLC's AC Immune position peaked at $50.6K in Q4 2024.
41 funds tracked by Wall St. Rank held AC Immune as of Q1 2025.

Based on RPO LLC's 13F filing for Q1 2025, filed 13 May 2025.